Thomas Cavanagh

Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom.

Symbios Medical Products LLC designs, manufactures and markets pain management systems. It designs pain management systems commonly known as ambulatory disposable pain pumps as the GOPump, GOPump Dual the GOBlock and GOBlock-SF Continuous Peripheral Nerve Block Pumps are used for the post operative management of acute pain and they deliver non-narcotic pain medication to surgical sites or provide a regional pain block to a specific area of the body below the neck. The company was founded in 2003 and is headquartered in Indianapolis, IN.